Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Relapsing viral hepatitis type A.

I M Jacobson, B J Nath, J L Dienstag

    Journal of Medical Virology
    |June 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Hepatitis A can sometimes relapse or last longer than expected, even for over six months. However, this prolonged viral hepatitis A course does not change its typically good prognosis.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Assessment of quorum sensing effects of tyrosol on fermentative performance by chief ethnic fermentative yeasts from northeast India.

    Journal of applied microbiology·2020
    Same author

    Sofosbuvir and velpatasvir with or without voxilaprevir in direct-acting antiviral-naïve chronic hepatitis C: patient-reported outcomes from POLARIS 2 and 3.

    Alimentary pharmacology & therapeutics·2017
    Same author

    Time to viral suppression is not related to achievement of SVR12 in HCV GT1-infected patients treated with ombitasvir/paritaprevir/ritonavir and dasabuvir with or without ribavirin.

    Journal of viral hepatitis·2016
    Same author

    Proinflammatory cytokine interferon-γ and microbiome-derived metabolites dictate epigenetic switch between forkhead box protein 3 isoforms in coeliac disease.

    Clinical and experimental immunology·2016
    Same author

    Antiviral response and resistance analysis of treatment-naïve HCV-infected patients receiving single and multiple doses of GS-9190.

    Journal of viral hepatitis·2016
    Same author

    Simeprevir with peginterferon/ribavirin for treatment of chronic hepatitis C virus genotype 1 infection: pooled safety analysis from Phase IIb and III studies.

    Journal of viral hepatitis·2014
    Same journal

    Favipiravir Is Associated With Reduced 28-Day Mortality in Severe Fever With Thrombocytopenia Syndrome: A Multicenter Propensity Score-Matched Study.

    Journal of medical virology·2026
    Same journal

    Defining Mechanistic Parameters for Covalent CD4-Based CAR-T Cells in HIV Reservoir Control.

    Journal of medical virology·2026
    Same journal

    Development and Application of a Quadruplex TaqMan-MGB qPCR Assay for Simultaneous Detection of Important Mosquito-Borne Orthoflaviviruses.

    Journal of medical virology·2026
    Same journal

    sVCAM-1 and Hematological Profiles Are Associated With CD4-Defined Disease Status in HIV Infection.

    Journal of medical virology·2026
    Same journal

    An Explainable Machine Learning Model for Early Prediction of Incident Myocardial Injury in Patients With Severe Fever With Thrombocytopenia Syndrome.

    Journal of medical virology·2026
    Same journal

    Global Performance of Human Papillomavirus Typing, Screening, and Evaluation As Assessed Using Proficiency Panels Traceable to International Standards: A Retrospective Analysis, 2008-2024.

    Journal of medical virology·2026
    See all related articles

    Area of Science:

    • Hepatology
    • Virology
    • Infectious Diseases

    Background:

    • Hepatitis A virus (HAV) infection typically presents as an acute illness.
    • Protracted or relapsing courses of viral hepatitis are uncommon but documented for some viral infections.

    Observation:

    • This case series describes three patients with serologically confirmed hepatitis A exhibiting a relapsing clinical course.
    • One patient experienced aminotransferase elevations persisting beyond six months, indicating a protracted disease course.

    Findings:

    • Despite the relapsing or protracted nature, all three patients with hepatitis A ultimately achieved full recovery.
    • A relapsing or protracted course of hepatitis A did not appear to negatively impact the overall benign prognosis.

    Related Experiment Videos

    Implications:

    • These findings suggest that clinicians should reassure patients experiencing prolonged or relapsing hepatitis A regarding the generally favorable long-term outcome.
    • Understanding the spectrum of hepatitis A clinical presentations is crucial for accurate diagnosis and patient management.